Cargando…

Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model

The genus Enterococcus includes two Gram-positive pathogens of particular clinical relevance: E. faecalis and E. faecium. Infections with each of these pathogens are becoming more frequent, particularly in the case of hospital-acquired infections. Like most other bacterial species of clinical import...

Descripción completa

Detalles Bibliográficos
Autores principales: Revtovich, Alexey V., Tjahjono, Elissa, Singh, Kavindra V., Hanson, Blake M., Murray, Barbara E., Kirienko, Natalia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116795/
https://www.ncbi.nlm.nih.gov/pubmed/33996637
http://dx.doi.org/10.3389/fcimb.2021.667327
_version_ 1783691472972808192
author Revtovich, Alexey V.
Tjahjono, Elissa
Singh, Kavindra V.
Hanson, Blake M.
Murray, Barbara E.
Kirienko, Natalia V.
author_facet Revtovich, Alexey V.
Tjahjono, Elissa
Singh, Kavindra V.
Hanson, Blake M.
Murray, Barbara E.
Kirienko, Natalia V.
author_sort Revtovich, Alexey V.
collection PubMed
description The genus Enterococcus includes two Gram-positive pathogens of particular clinical relevance: E. faecalis and E. faecium. Infections with each of these pathogens are becoming more frequent, particularly in the case of hospital-acquired infections. Like most other bacterial species of clinical importance, antimicrobial resistance (and, specifically, multi-drug resistance) is an increasing threat, with both species considered to be of particular importance by the World Health Organization and the US Centers for Disease Control. The threat of antimicrobial resistance is exacerbated by the staggering difference in the speeds of development for the discovery and development of the antimicrobials versus resistance mechanisms. In the search for alternative strategies, modulation of host-pathogen interactions in general, and virulence inhibition in particular, have drawn substantial attention. Unfortunately, these approaches require a fairly comprehensive understanding of virulence determinants. This requirement is complicated by the fact that enterococcal infection models generally require vertebrates, making them slow, expensive, and ethically problematic, particularly when considering the thousands of animals that would be needed for the early stages of experimentation. To address this problem, we developed the first high-throughput C. elegans–E. faecium infection model involving host death. Importantly, this model recapitulates many key aspects of murine peritonitis models, including utilizing similar virulence determinants. Additionally, host death is independent of peroxide production, unlike other E. faecium–C. elegans virulence models, which allows the assessment of other virulence factors. Using this system, we analyzed a panel of lab strains with deletions of targeted virulence factors. Although removal of certain virulence factors (e.g., Δfms15) was sufficient to affect virulence, multiple deletions were generally required to affect pathogenesis, suggesting that host-pathogen interactions are multifactorial. These data were corroborated by genomic analysis of selected isolates with high and low levels of virulence. We anticipate that this platform will be useful for identifying new treatments for E. faecium infection.
format Online
Article
Text
id pubmed-8116795
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81167952021-05-14 Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model Revtovich, Alexey V. Tjahjono, Elissa Singh, Kavindra V. Hanson, Blake M. Murray, Barbara E. Kirienko, Natalia V. Front Cell Infect Microbiol Cellular and Infection Microbiology The genus Enterococcus includes two Gram-positive pathogens of particular clinical relevance: E. faecalis and E. faecium. Infections with each of these pathogens are becoming more frequent, particularly in the case of hospital-acquired infections. Like most other bacterial species of clinical importance, antimicrobial resistance (and, specifically, multi-drug resistance) is an increasing threat, with both species considered to be of particular importance by the World Health Organization and the US Centers for Disease Control. The threat of antimicrobial resistance is exacerbated by the staggering difference in the speeds of development for the discovery and development of the antimicrobials versus resistance mechanisms. In the search for alternative strategies, modulation of host-pathogen interactions in general, and virulence inhibition in particular, have drawn substantial attention. Unfortunately, these approaches require a fairly comprehensive understanding of virulence determinants. This requirement is complicated by the fact that enterococcal infection models generally require vertebrates, making them slow, expensive, and ethically problematic, particularly when considering the thousands of animals that would be needed for the early stages of experimentation. To address this problem, we developed the first high-throughput C. elegans–E. faecium infection model involving host death. Importantly, this model recapitulates many key aspects of murine peritonitis models, including utilizing similar virulence determinants. Additionally, host death is independent of peroxide production, unlike other E. faecium–C. elegans virulence models, which allows the assessment of other virulence factors. Using this system, we analyzed a panel of lab strains with deletions of targeted virulence factors. Although removal of certain virulence factors (e.g., Δfms15) was sufficient to affect virulence, multiple deletions were generally required to affect pathogenesis, suggesting that host-pathogen interactions are multifactorial. These data were corroborated by genomic analysis of selected isolates with high and low levels of virulence. We anticipate that this platform will be useful for identifying new treatments for E. faecium infection. Frontiers Media S.A. 2021-04-29 /pmc/articles/PMC8116795/ /pubmed/33996637 http://dx.doi.org/10.3389/fcimb.2021.667327 Text en Copyright © 2021 Revtovich, Tjahjono, Singh, Hanson, Murray and Kirienko https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Revtovich, Alexey V.
Tjahjono, Elissa
Singh, Kavindra V.
Hanson, Blake M.
Murray, Barbara E.
Kirienko, Natalia V.
Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
title Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
title_full Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
title_fullStr Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
title_full_unstemmed Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
title_short Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
title_sort development and characterization of high-throughput caenorhabditis elegans – enterococcus faecium infection model
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116795/
https://www.ncbi.nlm.nih.gov/pubmed/33996637
http://dx.doi.org/10.3389/fcimb.2021.667327
work_keys_str_mv AT revtovichalexeyv developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel
AT tjahjonoelissa developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel
AT singhkavindrav developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel
AT hansonblakem developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel
AT murraybarbarae developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel
AT kirienkonataliav developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel